Goldman Sachs Group Inc Alkermes Plc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,746,157 shares of ALKS stock, worth $51.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,746,157
Previous 1,238,176 41.03%
Holding current value
$51.9 Million
Previous $29.8 Million 63.79%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.01 - $28.55 $11.7 Million - $14.5 Million
507,981 Added 41.03%
1,746,157 $48.9 Million
Q2 2024

Aug 13, 2024
SELL
$23.21 - $27.24 $3.42 Million - $4.01 Million
-147,171 Reduced 10.62%
1,238,176 $29.8 Million
Q1 2024

May 15, 2024
SELL
$26.4 - $32.56 $461,260 - $568,888
-17,472 Reduced 1.25%
1,385,347 $37.5 Million
Q4 2023

Feb 13, 2024
SELL
$23.37 - $28.68 $12.2 Million - $15 Million
-523,805 Reduced 27.19%
1,402,819 $38.9 Million
Q3 2023

May 14, 2024
BUY
$27.17 - $31.97 $14.2 Million - $16.7 Million
523,805 Added 37.34%
1,926,624 $54 Million
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $7.68 Million - $9.04 Million
282,660 Added 17.19%
1,926,624 $54 Million
Q2 2023

May 14, 2024
BUY
$28.34 - $33.63 $8.58 Million - $10.2 Million
302,696 Added 22.57%
1,643,964 $51.5 Million
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $8.58 Million - $10.2 Million
302,696 Added 22.57%
1,643,964 $51.5 Million
Q1 2023

May 14, 2024
SELL
$25.31 - $29.02 $13.3 Million - $15.2 Million
-524,639 Reduced 28.12%
1,341,268 $37.8 Million
Q1 2023

May 11, 2023
SELL
$25.31 - $29.02 $13.3 Million - $15.2 Million
-524,639 Reduced 28.12%
1,341,268 $37.8 Million
Q4 2022

May 14, 2024
SELL
$21.94 - $26.24 $5.23 Million - $6.26 Million
-238,566 Reduced 11.34%
1,865,907 $48.8 Million
Q4 2022

Feb 13, 2023
SELL
$21.94 - $26.24 $5.23 Million - $6.26 Million
-238,566 Reduced 11.34%
1,865,907 $48.8 Million
Q3 2022

May 14, 2024
SELL
$22.0 - $31.87 $3.95 Million - $5.72 Million
-179,325 Reduced 7.85%
2,104,473 $47 Million
Q3 2022

Nov 10, 2022
SELL
$22.0 - $31.87 $3.95 Million - $5.72 Million
-179,325 Reduced 7.85%
2,104,473 $47 Million
Q2 2022

May 14, 2024
BUY
$26.4 - $30.54 $23.3 Million - $26.9 Million
880,979 Added 62.8%
2,283,798 $68 Million
Q2 2022

Aug 15, 2022
SELL
$26.4 - $30.54 $33,871 - $39,182
-1,283 Reduced 0.06%
2,283,798 $68 Million
Q1 2022

May 16, 2022
BUY
$23.07 - $27.99 $7.29 Million - $8.85 Million
316,115 Added 16.05%
2,285,081 $60.1 Million
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $1.62 Million - $2.42 Million
75,453 Added 3.98%
1,968,966 $45.8 Million
Q3 2021

Nov 10, 2021
BUY
$23.37 - $32.13 $44.3 Million - $60.8 Million
1,893,513 New
1,893,513 $58.4 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email